Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
<h4>Aims</h4> <p>Renin-angiotensin system blockers reduce the incidence and progression of microalbuminuria and the subsequent development of end-stage renal disease (ESRD) in patients with type 2 diabetes. We aimed to examine the effect of valsartan on kidney outcomes in patients...
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
Wiley
2017
|